NASDAQ:MDRXAllscripts Healthcare Solutions Stock Price, Forecast & News

Allscripts Healthcare Solutions' stock was trading at $6.31 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MDRX shares have increased by 0.2% and is now trading at $6.32. View which stocks have been most impacted by Coronavirus.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allscripts Healthcare Solutions in the last year. There are currently 2 sell ratings, 7 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Allscripts Healthcare Solutions.

Allscripts Healthcare Solutions is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Allscripts Healthcare Solutions.

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) issued its quarterly earnings results on Thursday, May, 7th. The software maker reported $0.09 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.15 by $0.06. The software maker earned $416.70 million during the quarter, compared to the consensus estimate of $421.14 million. Allscripts Healthcare Solutions had a negative net margin of 11.10% and a positive return on equity of 4.98%. The firm's quarterly revenue was down 3.5% on a year-over-year basis. During the same period last year, the firm posted $0.16 earnings per share. View Allscripts Healthcare Solutions' earnings history.

Allscripts Healthcare Solutions announced that its Board of Directors has approved a share repurchase program on Thursday, August 2nd 2018, which authorizes the company to repurchase $250,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 11.3% of its shares through open market purchases. Shares repurchase programs are often an indication that the company's management believes its shares are undervalued.

Allscripts Healthcare Solutions issued an update on its first quarter 2020 After-Hours earnings guidance on Monday, March, 2nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $420-430 million, compared to the consensus revenue estimate of $450.84 million.

13 Wall Street analysts have issued twelve-month price targets for Allscripts Healthcare Solutions' stock. Their forecasts range from $6.00 to $13.00. On average, they anticipate Allscripts Healthcare Solutions' stock price to reach $8.65 in the next twelve months. This suggests a possible upside of 36.9% from the stock's current price. View analysts' price targets for Allscripts Healthcare Solutions.

Press coverage about MDRX stock has been trending somewhat positive recently, InfoTrie Sentiment reports. The research group identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Allscripts Healthcare Solutions earned a media sentiment score of 2.0 on InfoTrie's scale. They also assigned media headlines about the software maker a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news aboutAllscripts Healthcare Solutions.

Some companies that are related to Allscripts Healthcare Solutions include Cerner (CERN), Omnicell (OMCL), HMS (HMSY), Cortexyme (CRTX), HealthStream (HSTM), Vocera Communications (VCRA) and Computer Programs & Systems (CPSI). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Allscripts Healthcare Solutions investors own include Advanced Micro Devices (AMD), Netflix (NFLX), Walgreens Boots Alliance (WBA), Starbucks (SBUX), Activision Blizzard (ATVI), CVS Health (CVS), Ford Motor (F), Intel (INTC), Nuance Communications (NUAN) and Oasis Petroleum (OAS).

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

Allscripts Healthcare Solutions' stock is owned by many different retail and institutional investors. Top institutional investors include Fuller & Thaler Asset Management Inc. (4.49%), State Street Corp (3.38%), Fisher Asset Management LLC (3.29%), Silvercrest Asset Management Group LLC (2.78%), Geode Capital Management LLC (1.79%) and Invesco Ltd. (1.27%). Company insiders that own Allscripts Healthcare Solutions stock include Brian Farley, Dennis Olis, Mara G Aspinall, Michael Klayko, Paul Black, Richard J Poulton and Yancey L Spruill. View institutional ownership trends for Allscripts Healthcare Solutions.

MDRX stock was sold by a variety of institutional investors in the last quarter, including New York State Common Retirement Fund, Penn Capital Management Co. Inc., Fuller & Thaler Asset Management Inc., Balyasny Asset Management LLC, AXA, Principal Financial Group Inc., Rothschild & Co. Asset Management US Inc., and UBS Group AG. Company insiders that have sold Allscripts Healthcare Solutions company stock in the last year include Brian Farley, and Dennis Olis. View insider buying and selling activity for Allscripts Healthcare Solutions.

MDRX stock was acquired by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Invesco Ltd., Two Sigma Investments LP, Deutsche Bank AG, State Street Corp, Creative Planning, Paradigm Capital Management Inc. NY, and AJO LP. Company insiders that have bought Allscripts Healthcare Solutions stock in the last two years include Mara G Aspinall, Michael Klayko, Paul Black, Richard J Poulton, and Yancey L Spruill. View insider buying and selling activity for Allscripts Healthcare Solutions.

Shares of MDRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of MDRX stock can currently be purchased for approximately $6.32.

Allscripts Healthcare Solutions has a market capitalization of $1.03 billion and generates $1.77 billion in revenue each year. The software maker earns $-182,180,000.00 in net income (profit) each year or $0.47 on an earnings per share basis. Allscripts Healthcare Solutions employs 9,600 workers across the globe.

The official website for Allscripts Healthcare Solutions is www.allscripts.com.

Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. The software maker can be reached via phone at 800-334-8534 or via email at [email protected]